Jonathan Roses was quoted by Law360 in an article titled “Patent Cases To Watch In 2025.” In this article, Jon weighs in on the Edwards v. Meril case, mentioning that the Federal Circuit’s broad interpretation of the safe harbor doctrine leaves medical device companies without the clarity needed when importing goods for clinical trials. Read more (subscription required).